September 24, 2004
SpeculatingStocks.com Stock Pick: Sonus Pharmaceuticals, Inc. (SNUS)
Stock Price: $3.58 (short-term strong buy)
Sonus Pharmaceuticals, Inc. is an oncology drug development company. They are focused on driving product and corporate development activities towards building and expanding their pipeline of product candidates.
Their main drug candidate TOCOSOL Paclitaxel is about to enter phase 3 trials. This cancer drug is in a class of chemotherapeutic agents with annual worldwide sales of $2.5 billion. They are testing this drug for more than one use.
SNUS jumped today on heavy volume from its tight trading range. We believe the stock is going to continue to rise.
SpeculatingStocks.com Target Price: We expect SNUS to approach $4.50 in the next week.